Cargando…
2-Bromopalmitate targets retinoic acid receptor alpha and overcomes all-trans retinoic acid resistance of acute promyelocytic leukemia
Fatty acid oxidation dependency of leukemia cells has been documented in recent studies. Pharmacologic inhibition of fatty acid oxidation, thereby, displays significant effects in suppressing leukemia. 2-Bromopalmitate, a palmitate analogue, was initially identified as an inhibitor of fatty acid oxi...
Autores principales: | Lu, Ying, Yan, Jin-Song, Xia, Li, Qin, Kang, Yin, Qian-Qian, Xu, Hong-Tao, Gao, Meng-Qing, Qu, Xiao-Ning, Sun, Yu-Ting, Chen, Guo-Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ferrata Storti Foundation
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312026/ https://www.ncbi.nlm.nih.gov/pubmed/30076181 http://dx.doi.org/10.3324/haematol.2018.191916 |
Ejemplares similares
-
All-trans-retinoic acid–induced pseudotumor cerebri in acute promyelocytic leukemia
por: Anoop, T. M., et al.
Publicado: (2014) -
SCROTAL ULCERATION FOLLOWING ALL-TRANS RETINOIC ACID THERAPY FOR ACUTE PROMYELOCYTIC LEUKEMIA
por: Tazi, Illias, et al.
Publicado: (2011) -
Sweet’s syndrome during the treatment of acute promyelocytic leukemia with all-trans retinoic acid
por: Park, Chi Jun, et al.
Publicado: (2001) -
ZYH005, a novel DNA intercalator, overcomes all-trans retinoic acid resistance in acute promyelocytic leukemia
por: Tong, Qingyi, et al.
Publicado: (2018) -
All-Trans Retinoic Acid plus Arsenic Trioxide versus All-Trans Retinoic Acid plus Chemotherapy for Newly Diagnosed Acute Promyelocytic Leukemia: A Meta-Analysis
por: Ma, Yafang, et al.
Publicado: (2016)